WHO says stay at home, limit holiday season events midst COVID-19 surge

By Anthony Boadle BRASILIA (Reuters) - The World Health Organization's regional branch for the Americas recommended postponing or reducing mass gatherings during the approaching holiday season as cases surge again in many countries. 'This is not the time to be hosting any large gatherings ... during a pandemic, there is no such thing as a risk-free holiday season,' the Pan American Health Organization's Assistant Director Jarbas Barbosa said in a briefing Religious services should be held outdoors whenever possible or limited in size, he said

Reuters November 26, 2020 00:12:43 IST
WHO says stay at home, limit holiday season events midst COVID-19 surge

COVID-19 surge" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/26/2020-11-25T170814Z_1_LYNXMPEGAO1FC_RTROPTP_2_HEALTH-CORONAVIRUS-CDC-THANKSGIVING.jpg" alt="WHO says stay at home limit holiday season events midst COVID19 surge" width="300" height="225" />

By Anthony Boadle

BRASILIA (Reuters) - The World Health Organization's regional branch for the Americas recommended postponing or reducing mass gatherings during the approaching holiday season as cases surge again in many countries.

"This is not the time to be hosting any large gatherings ... during a pandemic, there is no such thing as a risk-free holiday season," the Pan American Health Organization's Assistant Director Jarbas Barbosa said in a briefing

Religious services should be held outdoors whenever possible or limited in size, he said.

With every gathering, every shopping trip and every travel plan increasing the chances of spreading the virus, the safest option for everyone is to stay at home, Barbosa said.

The organization does not recommend relying on laboratory tests for travelers because they do not guarantee safe travel or eliminate the risks related to infected travelers, he said.

The Americas reported more than 1.5 million cases of COVID-19 in the last seven days, the highest weekly number since the start of the coronavirus pandemic, the organization said on Wednesday.

The rapid surge of infections in the United States continues, and cases have accelerated in countries of North, Central and South America, it said.

In Canada, infections are rising particularly among the elderly and indigenous communities, Barbosa said.

(Reporting by Anthony Boadle; editing by Jonathan Oatis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Target holiday sales jump 17% as shoppers splurge online
Business

Target holiday sales jump 17% as shoppers splurge online

By Uday Sampath Kumar (Reuters) - Target Corp reported a 17.2% rise in comparable sales for the holiday season on Wednesday as its online sales more than doubled, thanks to faster deliveries and higher demand for home goods, electronics and beauty products.

S&P 500, Nasdaq tick higher on Intel boost
Business

S&P 500, Nasdaq tick higher on Intel boost

By Medha Singh and Devik Jain (Reuters) - The S&P 500 and the Nasdaq rose in choppy trading on Wednesday as Intel shares jumped thanks to a change in management while broader sentiment was muted after a recent run to record highs. Intel said it would replace Chief Executive Officer Bob Swan with VMware Inc CEO Pat Gelsinger next month

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses
Business

Bolivia signs contract with India's Serum Institute for 5 million AstraZeneca vaccine doses

By Danny Ramos LA PAZ (Reuters) - The Bolivian government said on Wednesday it had signed a contract with India's Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine. President Luis Arce said that combined with a recent deal to buy 5.2 million Sputnik V vaccine doses from Russia, Bolivia now expected to be able to inoculate all of its vaccinable population. Both vaccines require two doses to be given, meaning they would be used to inoculate a total of 5.1 million people from Bolivia's 11.51 million-strong population.